Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
D000914:Antibodies, Viral / Q000032:analysis*; D000956:Antigens, Viral; D002213:Capsid / Q000276:immunology; D002277:Carcinoma / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D002467:Cell Nucleus / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D009303:Nasopharyngeal Neoplasms / Q000276:immunology* / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011379:Prognosis
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M